Target intelligence / Profile preview

Bilayer vesicles (BV)

Target
BV
Molecular classification
Lipid assembly, Nanoparticle, Drug delivery system
01

Overview

Bilayer vesicles, most commonly known as liposomes, are spherical structures composed of one or more lipid bilayers surrounding an aqueous core. They are not therapeutic targets in the traditional sense, such as receptors or enzymes; rather, they serve as sophisticated drug delivery platforms designed to transport therapeutic agents to specific tissues or cells. By mimicking biological membranes, these vesicles can encapsulate both hydrophilic and hydrophobic drugs, protecting them from metabolic degradation and reducing off-target toxicities. In clinical practice, bilayer vesicles are utilized to improve the therapeutic index of potent drugs like doxorubicin and amphotericin B. Their properties, including size, charge, and surface modifications (e.g., PEGylation), are engineered to optimize circulation time and cellular uptake.

Other names
LiposomesLipid vesiclesUnilamellar vesiclesMultilamellar vesiclesLipid bilayers
02

Mechanism of action

Bilayer vesicles act as delivery vehicles that encapsulate therapeutic agents, protecting them from degradation and enhancing their pharmacokinetic profile by facilitating targeted delivery and reducing systemic toxicity.

03

Biological functions

Membrane formationMolecular transportCompartmentalizationCell signaling
04

Disease associations

Cancer (as delivery vehicle)Infectious disease (as delivery vehicle)Fungal infections
05

Safety considerations

Infusion-related reactionsLipid accumulationAccelerated blood clearance (ABC) phenomenonImmunogenicity
06

Interacting drugs

Amphotericin B (Ambisome)

4 more in the full profile.

Beyond the preview

Go deeper on Bilayer vesicles (BV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bilayer vesicles (BV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call